CD274 and gastric cancer: demonstrated that modulating miR-21 expression in post-gastrectomy patients alleviates surgery-induced Th17/Treg imbalance via PD-L1 axis regulation, suggesting that miR-21 inhibition is a viable therapeutic approach for mitigating postoperative immune dysfunction in advanced gastric cancer (140).